Michael J Lysaght
Overview
Explore the profile of Michael J Lysaght including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
240
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Patel R, Chang A, Lysaght M, Morgan J
J Tissue Eng Regen Med
. 2012 Feb;
7(6):470-8.
PMID: 22319007
We report here on the development and characterization of a cell-based system for the regulated delivery of bioactive insulin-like growth factor I (IGF-I). A stable mammalian cell line, CHO-K1 Tet-IGFI,...
2.
Zapanta C, Borovetz H, Lysaght M, Manning K
ASAIO J
. 2011 Aug;
57(5):466-9.
PMID: 21869622
Artificial organs education is often an overlooked field for many bioengineering and biomedical engineering students. The purpose of this article is to describe three different approaches to teaching artificial organs....
3.
Patel R, M Temu T, Jeanbart L, Morgan J, Lysaght M
ASAIO J
. 2009 Apr;
55(3):259-65.
PMID: 19390433
Insulin-like growth factor 1 (IGF-1) is a potent mitogen and differentiation factor with particular relevance to orthopedic tissue engineering. A biologically based Ca2+-alginate microcapsule vehicle, utilizing genetically modified primary normal...
4.
Lysaght M, Crager J
Tissue Eng Part A
. 2009 Mar;
15(7):1449-50.
PMID: 19327019
No abstract available.
5.
Shaldon S, Lysaght M
Nephrol Dial Transplant
. 2008 Aug;
23(9):2716-7.
PMID: 18710830
No abstract available.
6.
Lysaght M, Jaklenec A, Deweerd E
Tissue Eng Part A
. 2008 Mar;
14(2):305-15.
PMID: 18333783
This report draws upon data from a variety of sources to provide a detailed estimate of the current scope of private sector development and commercial activity in the aggregate field...
7.
Paek H, Campaner A, Kim J, Golden L, Aaron R, Ciombor D, et al.
Tissue Eng
. 2006 Aug;
12(7):1733-9.
PMID: 16889504
This study explores the suitability of using encapsulated genetically modified fibroblasts for orthopedic tissue engineering by examining cell survival and persistence of human transforming growth factor-beta (hTGF-beta) overexpression in xenogeneic...
8.
Paek H, Campaner A, Kim J, Aaron R, Ciombor D, Morgan J, et al.
ASAIO J
. 2005 Sep;
51(4):379-84.
PMID: 16156303
This study was undertaken to develop an in situ source of transforming growth factor-beta1 (TGF-beta1), one of several molecules potentially useful for a tissue-engineered bioartificial cartilage. Primary human fibroblasts and...
9.
Paek H, Morgan J, Lysaght M
Stem Cells
. 2005 May;
23(7):862-7.
PMID: 15888689
The source of insulin released from insulin-releasing cell clusters (IRCCs) differentiated from embryonic stem cells remains unclear. Rajagopal et al. have suggested that IRCCs do not synthesize but secrete insulin...
10.